Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment

The new human coronavirus named SARS-CoV-2 is a positive-sense RNA virus for which no specific drugs are currently available. A knowledge-based analysis strongly suggests a possible repositioning of the anti-HCV direct antiviral agent (DAA) Sofosbuvir as treatment for SARS-CoV-2. Indeed, the RNA-dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Buonaguro, Luigi, Buonaguro, Franco M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215134/
https://www.ncbi.nlm.nih.gov/pubmed/32419838
http://dx.doi.org/10.1186/s13027-020-00302-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215134/
https://www.ncbi.nlm.nih.gov/pubmed/32419838
http://dx.doi.org/10.1186/s13027-020-00302-x

Ejemplares similares